SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,277,712 | +53.9% | 281,895 | +5.7% | 0.92% | +91.9% |
| Q3 2022 | $1,480,000 | -20.5% | 266,679 | -25.4% | 0.48% | -26.2% |
| Q2 2022 | $1,862,000 | -23.6% | 357,465 | +20.6% | 0.65% | +1.7% |
| Q1 2022 | $2,437,000 | +46.5% | 296,508 | +165.2% | 0.64% | +59.7% |
| Q4 2021 | $1,664,000 | -55.4% | 111,803 | -35.0% | 0.40% | -70.2% |
| Q4 2020 | $3,735,000 | -19.6% | 172,047 | -62.8% | 1.35% | -2.0% |
| Q3 2020 | $4,645,000 | +283.6% | 462,170 | +196.3% | 1.37% | +1981.8% |
| Q2 2020 | $1,211,000 | +237.3% | 156,005 | +377.6% | 0.07% | -41.6% |
| Q4 2019 | $359,000 | – | 32,666 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |